329 related articles for article (PubMed ID: 1383329)
1. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
2. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
Bradbury LE; Goldmacher VS; Tedder TF
J Immunol; 1993 Sep; 151(6):2915-27. PubMed ID: 7690791
[TBL] [Abstract][Full Text] [Related]
3. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Matsumoto AK; Martin DR; Carter RH; Klickstein LB; Ahearn JM; Fearon DT
J Exp Med; 1993 Oct; 178(4):1407-17. PubMed ID: 7690834
[TBL] [Abstract][Full Text] [Related]
4. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
5. TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen.
Takahashi S; Doss C; Levy S; Levy R
J Immunol; 1990 Oct; 145(7):2207-13. PubMed ID: 2398277
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
7. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
[TBL] [Abstract][Full Text] [Related]
8. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
Fearon DT; Carter RH
Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
[TBL] [Abstract][Full Text] [Related]
9. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
[TBL] [Abstract][Full Text] [Related]
10. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
11. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules.
Schick MR; Levy S
J Immunol; 1993 Oct; 151(8):4090-7. PubMed ID: 8409388
[TBL] [Abstract][Full Text] [Related]
12. The CD19/CD21 signal transduction complex of B lymphocytes.
Tedder TF; Zhou LJ; Engel P
Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
[TBL] [Abstract][Full Text] [Related]
13. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
14. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
15. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
16. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
[TBL] [Abstract][Full Text] [Related]
17. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
Fearon DT
Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
[TBL] [Abstract][Full Text] [Related]
18. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
19. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells.
Barrett TB; Shu G; Clark EA
J Immunol; 1991 Mar; 146(6):1722-9. PubMed ID: 1706378
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R
Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
